--2025/Q1-- / 12.975M--
--2024/Q4-- / 18.171M--
Nov 6, 20242024/Q326.082M / 29.829M--
Aug 8, 20242024/Q214.417M / 13.286M--
May 9, 20242024/Q113.794M / 13.067M--
US Stock MarketDetailed Quotes
RXRX Recursion Pharmaceuticals
- 5.970
- +0.270+4.74%
Trading Nov 25 14:25 ET
1.71BMarket Cap-3876P/E (TTM)
6.480High5.830Low15.57MVolume5.940Open5.700Pre Close95.46MTurnover6.06%Turnover RatioLossP/E (Static)286.64MShares15.74052wk High3.26P/B1.53BFloat Cap5.60052wk Low--Dividend TTM257.07MShs Float42.810Historical High--Div YieldTTM11.40%Amplitude4.540Historical Low6.129Avg Price1Lot Size
Recursion Pharmaceuticals Key Stats
Recursion Pharmaceuticals Q3 2024 Earnings Date
Currency：USDNov 6, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 29.83M | 26.08M | -3.75M |
| Miss Est. | +183.19% | +147.62% | -12.56% |
| EPS | -0.35 | -0.34 | +0.01 |
| Beat Est. | +18.49% | +20.93% | +2.97% |
Analyst Rating
Nov 25, 2024
Recursion Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Recursion Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
